> top > docs > PMC:7205724 > spans > 36-223 > annotations

PMC:7205724 / 36-223 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 96-111 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 53-77 Chemical denotes immunosuppressive agents http://purl.obolibrary.org/obo/CHEBI_35705
T2 117-132 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T1 96-111 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulins http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T1 53-70 http://purl.obolibrary.org/obo/IDO_0000610 denotes immunosuppressive

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 117-132 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T2 4-78 Sentence denotes Rationale and hypothesis for the use of multiple immunosuppressive agents:
T3 79-132 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 134-144 Sentence denotes Highlights

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T5 2-3 -COLON- denotes :
T6 4-13 NN denotes Rationale
T7 14-17 CC denotes and
T8 18-28 NN denotes hypothesis
T9 29-32 IN denotes for
T10 33-36 DT denotes the
T11 37-40 NN denotes use
T12 41-43 IN denotes of
T13 44-52 JJ denotes multiple
T14 53-70 JJ denotes immunosuppressive
T15 71-77 NNS denotes agents
T16 77-78 -COLON- denotes :
T17 79-94 NNS denotes Anti-antibodies
T18 94-95 -COMMA- denotes ,
T19 96-111 NNS denotes immunoglobulins
T20 111-112 -COMMA- denotes ,
T21 113-116 CC denotes and
T22 117-132 NNS denotes corticosteroids
T23 134-144 NNS denotes Highlights
T24 145-146 IN denotes •
T25 148-152 NNP denotes IVIG
T26 152-153 -COMMA- denotes ,
T27 154-162 VBN denotes combined
T28 163-167 IN denotes with
T29 168-181 NN denotes moderate-dose
T30 182-184 IN denotes of
R5 T6 T7 arg1Of Rationale,and
R6 T8 T7 arg2Of hypothesis,and
R7 T7 T9 arg1Of and,for
R8 T11 T9 arg2Of use,for
R9 T11 T10 arg1Of use,the
R10 T11 T12 arg1Of use,of
R11 T15 T12 arg2Of agents,of
R12 T15 T13 arg1Of agents,multiple
R13 T15 T14 arg1Of agents,immunosuppressive
R14 T7 T16 arg1Of and,:
R15 T17 T18 arg1Of Anti-antibodies,","
R16 T19 T18 arg2Of immunoglobulins,","
R17 T21 T20 arg1Of and,","
R18 T18 T21 arg1Of ",",and
R19 T22 T21 arg2Of corticosteroids,and
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 96-111 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T2 4-78 Sentence denotes Rationale and hypothesis for the use of multiple immunosuppressive agents:
T3 79-132 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 134-144 Sentence denotes Highlights